Introduction: Generic injectable manufacturers face a unique quality challenge: unlike oral or topical products, injectables can expose patients directly to […]
Extractables and Leachables (E&L) Testing for Generic Injectable Drug Products at a CDMO Read More »
Introduction: USP <1663> and <1664> E&L Testing is the analytical backbone that connects a packaging or delivery-system material to a
Introduction Single-Use Systems and GMP Extractables and Leachables (E&L) Testing establishes the analytical foundation necessary for detecting, identifying, quantifying, and
Introduction Designing a GMP-Compliant Extractables and Leachables (E&L) Study requires a structured, risk-based approach that brings together advanced analytical chemistry,
Introduction: Extractable & Leachable Testing for Clinical to Commercial Scale-Up is essential because changes introduced during manufacturing scale-up can alter
Introduction Designing a GMP-Compliant Extractables and Leachables (E&L) Study for container closure systems requires a systematic, risk-tiered analytical framework to
Introduction Extractables and Leachables (E&L) Requirements for Single-Use Bioprocessing in cell therapy programs define the analytical frameworks and risk assessment
Introduction Outsourcing Extractables and Leachables (E&L) Testing to a Drug Establishment License (DEL) holder ensures that analytical data is generated
Introduction Achieving Extractables and Leachables (E&L) Compliance for a Dry Powder Inhaler intended for European Medicines Agency (EMA) approval demands
Introduction: Extractables and Leachables Testing for Prefilled Syringes has become an essential requirement for pharmaceutical companies developing injectable biologics, biosimilars,
